Annual Drug Patent Expirations for PICATO
Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for PICATO.
This drug has forty-eight patent family members in twenty-five countries.
The generic ingredient in PICATO is ingenol mebutate. One supplier is listed for this compound. Additional details are available on the ingenol mebutate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
